<DOC>
	<DOCNO>NCT03068364</DOCNO>
	<brief_summary>Risk stratification hypertensive patient include assessment traditional cardiovascular risk factor subclinical target organ damage particularly leave ventricular hypertrophy ( LVH ) . LVH may routinely screen transthoracic echocardiography measuring leave ventricular mass ( LVM ) . However , transthoracic echocardiography suffers several pitfall : poor reproducibility , technical limitation unavailability first evaluation general practitioner . Other biomarkers may particularly helpful hypertension risk stratification . The amplitude R wave aVL lead simple validate ECG parameter LVH strong predictor cardiovascular event mortality . Plasma N-terminal pro Brain Natriuretic Peptide ( NT-proBNP ) also strongly relate LVM independent predictor all-cause mortality hypertension . The main objective study determine additive prognostic value R wave aVL NT proBNP all-cause cardiovascular mortality . Secondary objective determine addition prognostic value NT-proBNP R wave aVL combine comparison marker take account This study include 1600 patient work-up hypertension Cardiology Department Croix-Rousse Hospital ( Hospices Civils de Lyon , Lyon , France ) January 1997 January 2014 . Their data collect Access database ; vital status obtain INSEE unit CÃ©piDC .</brief_summary>
	<brief_title>Biological Electrocardiographic Biomarkers Risk Stratification Hypertension .</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>&gt; 18 year old men woman questionnaire completion physical exam first stay Cardiology Department January 1997 January 2014 . Patients refusal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Mortality</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Left ventricular hypertrophy</keyword>
	<keyword>NT-proBNP</keyword>
	<keyword>ECG</keyword>
	<keyword>Transthoracic echocardiography</keyword>
</DOC>